A citation-based method for searching scientific literature

N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
Times Cited: 121







List of co-cited articles
690 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
787
29

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
320
22

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
92
21

Polygenes, risk prediction, and targeted prevention of breast cancer.
Paul D P Pharoah, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder. N Engl J Med 2008
403
19

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, Edward J Saunders, Daniel A Leongamornlert, Malgorzata Tymrakiewicz, Maya Ghoussaini, Craig Luccarini, Joe Dennis, Sarah Jugurnauth-Little,[...]. Nat Genet 2013
416
19

Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
Montserrat Garcia-Closas, Necdet Burak Gunsoy, Nilanjan Chatterjee. J Natl Cancer Inst 2014
76
21

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
63
25

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
13

Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
61
21

Polygenic susceptibility to breast cancer and implications for prevention.
Paul D P Pharoah, Antonis Antoniou, Martin Bobrow, Ron L Zimmern, Douglas F Easton, Bruce A J Ponder. Nat Genet 2002
578
12

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
12

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
693
12

Genome-wide association study identifies novel breast cancer susceptibility loci.
Douglas F Easton, Karen A Pooley, Alison M Dunning, Paul D P Pharoah, Deborah Thompson, Dennis G Ballinger, Jeffery P Struewing, Jonathan Morrison, Helen Field, Robert Luben,[...]. Nature 2007
11


Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.
Kyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, Sander Canisius, Joe Dennis, Michael J Lush, Mel J Maranian, Manjeet K Bolla, Qin Wang, Mitul Shah,[...]. Nat Genet 2015
361
11

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
317
11

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
117
10


Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
Hatef Darabi, Kamila Czene, Wanting Zhao, Jianjun Liu, Per Hall, Keith Humphreys. Breast Cancer Res 2012
84
10

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
Montserrat Garcia-Closas, Fergus J Couch, Sara Lindstrom, Kyriaki Michailidou, Marjanka K Schmidt, Mark N Brook, Nick Orr, Suhn Kyong Rhie, Elio Riboli, Heather S Feigelson,[...]. Nat Genet 2013
310
9


A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact.
Robert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, Gianluca Severi, Ali Amin Al Olama, Lesley McGuffog, Zsofia Kote-Jarai, Michelle Guy, Lynne T O'Brien, Amanda L Hall,[...]. Genet Epidemiol 2011
62
14

How can polygenic inheritance be used in population screening for common diseases?
Muin J Khoury, A Cecile J W Janssens, David F Ransohoff. Genet Med 2013
35
25

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
349
9

Performance of common genetic variants in breast-cancer risk models.
Sholom Wacholder, Patricia Hartge, Ross Prentice, Montserrat Garcia-Closas, Heather Spencer Feigelson, W Ryan Diver, Michael J Thun, David G Cox, Susan E Hankinson, Peter Kraft,[...]. N Engl J Med 2010
324
8

Prevention of breast cancer in the context of a national breast screening programme.
A Howell, S Astley, J Warwick, P Stavrinos, S Sahin, S Ingham, H McBurney, B Eckersley, M Harvie, M Wilson,[...]. J Intern Med 2012
21
38

Stratified cancer screening: the practicalities of implementation.
T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles,[...]. Public Health Genomics 2013
38
21

Multiple newly identified loci associated with prostate cancer susceptibility.
Rosalind A Eeles, Zsofia Kote-Jarai, Graham G Giles, Ali Amin Al Olama, Michelle Guy, Sarah K Jugurnauth, Shani Mulholland, Daniel A Leongamornlert, Stephen M Edwards, Jonathan Morrison,[...]. Nat Genet 2008
646
8

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
Zsofia Kote-Jarai, Ali Amin Al Olama, Graham G Giles, Gianluca Severi, Johanna Schleutker, Maren Weischer, Daniele Campa, Elio Riboli, Tim Key, Henrik Gronberg,[...]. Nat Genet 2011
222
8

Screening and prostate-cancer mortality in a randomized European study.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Stefano Ciatto, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Hans Lilja, Marco Zappa,[...]. N Engl J Med 2009
8

The genetic epidemiology of prostate cancer and its clinical implications.
Rosalind Eeles, Chee Goh, Elena Castro, Elizabeth Bancroft, Michelle Guy, Ali Amin Al Olama, Douglas Easton, Zsofia Kote-Jarai. Nat Rev Urol 2014
151
8

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
8

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Fritz H Schröder, Jonas Hugosson, Monique J Roobol, Teuvo L J Tammela, Marco Zappa, Vera Nelen, Maciej Kwiatkowski, Marcos Lujan, Liisa Määttänen, Hans Lilja,[...]. Lancet 2014
875
8

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.
Ali Amin Al Olama, Zsofia Kote-Jarai, Sonja I Berndt, David V Conti, Fredrick Schumacher, Ying Han, Sara Benlloch, Dennis J Hazelett, Zhaoming Wang, Ed Saunders,[...]. Nat Genet 2014
301
8

Association analysis identifies 65 new breast cancer risk loci.
Kyriaki Michailidou, Sara Lindström, Joe Dennis, Jonathan Beesley, Shirley Hui, Siddhartha Kar, Audrey Lemaçon, Penny Soucy, Dylan Glubb, Asha Rostamianfar,[...]. Nature 2017
574
8

Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Matthew E Mealiffe, Renee P Stokowski, Brian K Rhees, Ross L Prentice, Mary Pettinger, David A Hinds. J Natl Cancer Inst 2010
119
7

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
David J Hunter, Peter Kraft, Kevin B Jacobs, David G Cox, Meredith Yeager, Susan E Hankinson, Sholom Wacholder, Zhaoming Wang, Robert Welch, Amy Hutchinson,[...]. Nat Genet 2007
7

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
Juliet D French, Maya Ghoussaini, Stacey L Edwards, Kerstin B Meyer, Kyriaki Michailidou, Shahana Ahmed, Sofia Khan, Mel J Maranian, Martin O'Reilly, Kristine M Hillman,[...]. Am J Hum Genet 2013
157
7

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Stig E Bojesen, Karen A Pooley, Sharon E Johnatty, Jonathan Beesley, Kyriaki Michailidou, Jonathan P Tyrer, Stacey L Edwards, Hilda A Pickett, Howard C Shen, Chanel E Smart,[...]. Nat Genet 2013
399
7

Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.
Julius Gudmundsson, Patrick Sulem, Andrei Manolescu, Laufey T Amundadottir, Daniel Gudbjartsson, Agnar Helgason, Thorunn Rafnar, Jon T Bergthorsson, Bjarni A Agnarsson, Adam Baker,[...]. Nat Genet 2007
657
7

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
787
7



Assessing women at high risk of breast cancer: a review of risk assessment models.
Eitan Amir, Orit C Freedman, Bostjan Seruga, D Gareth Evans. J Natl Cancer Inst 2010
269
7

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.
Nora Pashayan, Paul Dp Pharoah, Johanna Schleutker, Kirsi Talala, Teuvo Lj Tammela, Liisa Määttänen, Patricia Harrington, Jonathan Tyrer, Rosalind Eeles, Stephen W Duffy,[...]. Br J Cancer 2015
22
31

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
537
7

Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Paige Maas, Myrto Barrdahl, Amit D Joshi, Paul L Auer, Mia M Gaudet, Roger L Milne, Fredrick R Schumacher, William F Anderson, David Check, Subham Chattopadhyay,[...]. JAMA Oncol 2016
169
7



Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999
506
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.